-
1
-
-
0035902442
-
Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: A longitudinal study by high-resolution, noninvasive magnetic resonance imaging
-
Corti R, Fayad ZA, Fuster V, et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001;104:249-52.
-
(2001)
Circulation
, vol.104
, pp. 249-252
-
-
Corti, R.1
Fayad, Z.A.2
Fuster, V.3
-
2
-
-
0027981582
-
Effect of simvastatin on coronary atheroma: The Multicentre Anti-Atheroma Study (MAAS)
-
Oliver MF, de Feyter PJ, Lubsen J, et al. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 1994;344:633-8.
-
(1994)
Lancet
, vol.344
, pp. 633-638
-
-
Oliver, M.F.1
De Feyter, P.J.2
Lubsen, J.3
-
3
-
-
0037016049
-
Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: Two years' follow-up by high-resolution noninvasive magnetic resonance imaging
-
Corti R, Fuster V, Fayad ZA, et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002;106:2884-7.
-
(2002)
Circulation
, vol.106
, pp. 2884-2887
-
-
Corti, R.1
Fuster, V.2
Fayad, Z.A.3
-
4
-
-
0035943069
-
Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease
-
Schartl M, Bocksch W, Koschyk DH, et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001;104:387-92.
-
(2001)
Circulation
, vol.104
, pp. 387-392
-
-
Schartl, M.1
Bocksch, W.2
Koschyk, D.H.3
-
5
-
-
0035806626
-
Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study
-
PRINCE Investigators
-
Albert MA, Danielson E, Rifai N, Ridker PM; PRINCE Investigators. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001;286:64-70.
-
(2001)
JAMA
, vol.286
, pp. 64-70
-
-
Albert, M.A.1
Danielson, E.2
Rifai, N.3
Ridker, P.M.4
-
6
-
-
0346736491
-
Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
-
Hernández-Perera O, Pérez-Sala D, Navarro-Antolín J, et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 1998;101:2711-9.
-
(1998)
J Clin Invest
, vol.101
, pp. 2711-2719
-
-
Hernández-Perera, O.1
Pérez-Sala, D.2
Navarro-Antolín, J.3
-
7
-
-
34948825774
-
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction
-
Guzik TJ, Hoch NE, Brown KA, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007;204:2449-60.
-
(2007)
J Exp Med
, vol.204
, pp. 2449-2460
-
-
Guzik, T.J.1
Hoch, N.E.2
Brown, K.A.3
-
8
-
-
0344373794
-
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
-
(2002)
JAMA
, vol.288
, pp. 2981-2997
-
-
-
9
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
-
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
Bosch, J.4
Davies, R.5
Dagenais, G.6
-
10
-
-
2942695964
-
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial
-
Weber MA, Julius S, Kjeldsen SE, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet 2004;363:2049-51.
-
(2004)
Lancet
, vol.363
, pp. 2049-2051
-
-
Weber, M.A.1
Julius, S.2
Kjeldsen, S.E.3
-
11
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
-
(2002)
Lancet
, vol.359
, pp. 995-1003
-
-
Dahlöf, B.1
Devereux, R.B.2
Kjeldsen, S.E.3
-
12
-
-
0028365310
-
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
-
Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994;74:1141-8.
-
(1994)
Circ Res
, vol.74
, pp. 1141-1148
-
-
Griendling, K.K.1
Minieri, C.A.2
Ollerenshaw, J.D.3
Alexander, R.W.4
-
13
-
-
20844456215
-
Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients
-
Koh KK, Quon MJ, Han SH, et al. Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients. Circulation 2004;110:3687-92.
-
(2004)
Circulation
, vol.110
, pp. 3687-3692
-
-
Koh, K.K.1
Quon, M.J.2
Han, S.H.3
-
14
-
-
33845486328
-
The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients
-
Han SH, Koh KK, Quon MJ, Lee Y, Shin EK. The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients. Atherosclerosis 2007;190:205-11.
-
(2007)
Atherosclerosis
, vol.190
, pp. 205-211
-
-
Han, S.H.1
Koh, K.K.2
Quon, M.J.3
Lee, Y.4
Shin, E.K.5
-
15
-
-
34547156745
-
The effect of diet on simvastatin and losartan enhancement of endothelial function
-
Bayorh MA, Layas MF, Mann G, Feuerstein GZ, Eatman D. The effect of diet on simvastatin and losartan enhancement of endothelial function. Clin Exp Hypertens 2007;29:311-25.
-
(2007)
Clin Exp Hypertens
, vol.29
, pp. 311-325
-
-
Bayorh, M.A.1
Layas, M.F.2
Mann, G.3
Feuerstein, G.Z.4
Eatman, D.5
-
16
-
-
0037420492
-
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial
-
Sever PS, Dahlöf B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-58.
-
(2003)
Lancet
, vol.361
, pp. 1149-1158
-
-
Sever, P.S.1
Dahlöf, B.2
Poulter, N.R.3
-
17
-
-
0001539238
-
Effects of statins on vascular wall: Vasomotor function, inflammation, and plaque stability
-
Koh KK. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res 2000;47:648-57.
-
(2000)
Cardiovasc Res
, vol.47
, pp. 648-657
-
-
Koh, K.K.1
-
18
-
-
27644544308
-
Pleiotropic effects of statins: Benefit beyond cholesterol reduction? A meta-regression analysis
-
Robinson JG, Smith B, Maheshwari N, Schrott H. Pleiotropic effects of statins: benefit beyond cholesterol reduction? a meta-regression analysis. J Am Coll Cardiol 2005;46:1855-62.
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1855-1862
-
-
Robinson, J.G.1
Smith, B.2
Maheshwari, N.3
Schrott, H.4
-
20
-
-
0035162266
-
Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering
-
Sparrow CP, Burton CA, Hernandez M, et al. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol 2001;21:115-21.
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, pp. 115-121
-
-
Sparrow, C.P.1
Burton, C.A.2
Hernandez, M.3
-
21
-
-
0033408540
-
The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein e deficient mice
-
Hayek T, Attias J, Coleman R, et al. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice. Cardiovasc Res 1999;44:579-87.
-
(1999)
Cardiovasc Res
, vol.44
, pp. 579-587
-
-
Hayek, T.1
Attias, J.2
Coleman, R.3
-
22
-
-
77952531766
-
Multiplex coherent anti-stokes Raman spectroscopy images intact atheromatous lesions and concomitantly identifies distinct chemical profiles of atherosclerotic lipids
-
Kim SH, Lee ES, Lee JY, et al. Multiplex coherent anti-stokes Raman spectroscopy images intact atheromatous lesions and concomitantly identifies distinct chemical profiles of atherosclerotic lipids. Circ Res 2010;106:1332-41.
-
(2010)
Circ Res
, vol.106
, pp. 1332-1341
-
-
Kim, S.H.1
Lee, E.S.2
Lee, J.Y.3
-
23
-
-
0036066345
-
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients
-
Rezaie-Majd A, Maca T, Bucek RA, et al. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 2002;22:1194-9.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 1194-1199
-
-
Rezaie-Majd, A.1
Maca, T.2
Bucek, R.A.3
-
24
-
-
0034781127
-
Losartan inhibits the angiotensin II-induced modifications on fibrinolysis and matrix deposition by primary human vascular smooth muscle cells
-
Papakonstantinou E, Roth M, Kokkas B, Papadopoulos C, Karakiulakis G. Losartan inhibits the angiotensin II-induced modifications on fibrinolysis and matrix deposition by primary human vascular smooth muscle cells. J Cardiovasc Pharmacol 2001;38:715-28.
-
(2001)
J Cardiovasc Pharmacol
, vol.38
, pp. 715-728
-
-
Papakonstantinou, E.1
Roth, M.2
Kokkas, B.3
Papadopoulos, C.4
Karakiulakis, G.5
-
25
-
-
0036180776
-
Modulation of matrix metalloproteinase-1, its tissue inhibitor, and nuclear factor-kappa B by losartan in hypercholesterolemic rabbits
-
Chen H, Li D, Mehta JL. Modulation of matrix metalloproteinase-1, its tissue inhibitor, and nuclear factor-kappa B by losartan in hypercholesterolemic rabbits. J Cardiovasc Pharmacol 2002;39:332-9.
-
(2002)
J Cardiovasc Pharmacol
, vol.39
, pp. 332-339
-
-
Chen, H.1
Li, D.2
Mehta, J.L.3
-
26
-
-
33748372961
-
Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome
-
Park HK, Park EC, Bae SW, et al. Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome. Circulation 2006;114:886-93.
-
(2006)
Circulation
, vol.114
, pp. 886-893
-
-
Park, H.K.1
Park, E.C.2
Bae, S.W.3
-
27
-
-
20844438189
-
Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis
-
Martin-Ventura JL, Duran MC, Blanco-Colio LM, et al. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 2004;110:2216-9.
-
(2004)
Circulation
, vol.110
, pp. 2216-2219
-
-
Martin-Ventura, J.L.1
Duran, M.C.2
Blanco-Colio, L.M.3
|